Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.65
(-0.44%)
CNY 13.65
(-0.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 421.29 Million CNY | 27.85% |
| 2022 | 329.52 Million CNY | -4.13% |
| 2021 | 343.71 Million CNY | 24.08% |
| 2020 | 277.02 Million CNY | -29.36% |
| 2019 | 392.14 Million CNY | -5.13% |
| 2018 | 413.34 Million CNY | -10.99% |
| 2017 | 464.4 Million CNY | 17.97% |
| 2016 | 393.66 Million CNY | 4.51% |
| 2015 | 376.67 Million CNY | -15.33% |
| 2014 | 444.86 Million CNY | 5.85% |
| 2013 | 420.26 Million CNY | 26.91% |
| 2012 | 331.15 Million CNY | 13.43% |
| 2011 | 291.95 Million CNY | 12.83% |
| 2010 | 258.75 Million CNY | -15.8% |
| 2009 | 307.31 Million CNY | 12.27% |
| 2008 | 273.72 Million CNY | 9.85% |
| 2007 | 249.17 Million CNY | 27.91% |
| 2006 | 194.8 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 200.95 Million CNY | 100.92% |
| 2024 Q3 | 82.9 Million CNY | -58.75% |
| 2024 Q1 | 100.01 Million CNY | 1727.94% |
| 2023 FY | 421.29 Million CNY | 27.85% |
| 2023 Q4 | -6.14 Million CNY | -135.4% |
| 2023 Q1 | 169.22 Million CNY | 3190.23% |
| 2023 Q2 | 210.31 Million CNY | 24.28% |
| 2023 Q3 | 17.35 Million CNY | -91.75% |
| 2022 Q4 | 5.14 Million CNY | -76.04% |
| 2022 Q3 | 21.46 Million CNY | -88.26% |
| 2022 Q2 | 182.86 Million CNY | 52.32% |
| 2022 Q1 | 120.05 Million CNY | 136.23% |
| 2022 FY | 329.52 Million CNY | -4.13% |
| 2021 Q3 | 45.7 Million CNY | -69.43% |
| 2021 Q1 | 97.67 Million CNY | 448.75% |
| 2021 Q2 | 149.51 Million CNY | 53.08% |
| 2021 FY | 343.71 Million CNY | 24.08% |
| 2021 Q4 | 50.82 Million CNY | 11.19% |
| 2020 Q3 | 63.77 Million CNY | -61.22% |
| 2020 Q1 | 76.79 Million CNY | 24.82% |
| 2020 FY | 277.02 Million CNY | -29.36% |
| 2020 Q4 | -28 Million CNY | -143.91% |
| 2020 Q2 | 164.46 Million CNY | 114.16% |
| 2019 Q1 | 87.77 Million CNY | 88.69% |
| 2019 FY | 392.14 Million CNY | -5.13% |
| 2019 Q4 | 61.52 Million CNY | 9.65% |
| 2019 Q3 | 56.1 Million CNY | -69.95% |
| 2019 Q2 | 186.73 Million CNY | 112.73% |
| 2018 FY | 413.34 Million CNY | -10.99% |
| 2018 Q4 | 46.51 Million CNY | -51.99% |
| 2018 Q3 | 96.88 Million CNY | -48.03% |
| 2018 Q2 | 186.42 Million CNY | 123.23% |
| 2018 Q1 | 83.51 Million CNY | -27.99% |
| 2017 Q3 | 95.95 Million CNY | -45.62% |
| 2017 Q1 | 76.02 Million CNY | -1.87% |
| 2017 FY | 464.4 Million CNY | 17.97% |
| 2017 Q4 | 115.97 Million CNY | 20.87% |
| 2017 Q2 | 176.44 Million CNY | 132.08% |
| 2016 Q3 | 89.13 Million CNY | -42.4% |
| 2016 FY | 393.66 Million CNY | 4.51% |
| 2016 Q4 | 77.47 Million CNY | -13.08% |
| 2016 Q1 | 71.83 Million CNY | -22.92% |
| 2016 Q2 | 154.76 Million CNY | 115.43% |
| 2015 Q2 | 167.22 Million CNY | 228.68% |
| 2015 Q4 | 93.2 Million CNY | 40.9% |
| 2015 FY | 376.67 Million CNY | -15.33% |
| 2015 Q1 | 50.87 Million CNY | -57.05% |
| 2015 Q3 | 66.14 Million CNY | -60.44% |
| 2014 Q2 | 163.42 Million CNY | 126.99% |
| 2014 FY | 444.86 Million CNY | 5.85% |
| 2014 Q4 | 118.46 Million CNY | 44.4% |
| 2014 Q3 | 82.04 Million CNY | -49.8% |
| 2014 Q1 | 71.99 Million CNY | -32.81% |
| 2013 Q4 | 107.14 Million CNY | 10.26% |
| 2013 FY | 420.26 Million CNY | 26.91% |
| 2013 Q1 | 71.98 Million CNY | 18.8% |
| 2013 Q2 | 143.96 Million CNY | 99.98% |
| 2013 Q3 | 97.17 Million CNY | -32.5% |
| 2012 Q2 | 126.43 Million CNY | 99.5% |
| 2012 FY | 331.15 Million CNY | 13.43% |
| 2012 Q4 | 60.59 Million CNY | -24.95% |
| 2012 Q1 | 63.37 Million CNY | 22.61% |
| 2012 Q3 | 80.74 Million CNY | -36.14% |
| 2011 Q3 | 73.41 Million CNY | -36.02% |
| 2011 Q1 | 52.11 Million CNY | 18.03% |
| 2011 Q2 | 114.73 Million CNY | 120.16% |
| 2011 FY | 291.95 Million CNY | 12.83% |
| 2011 Q4 | 51.68 Million CNY | -29.59% |
| 2010 Q4 | 44.15 Million CNY | -29.31% |
| 2010 Q3 | 62.46 Million CNY | -38.81% |
| 2010 FY | 258.75 Million CNY | -15.8% |
| 2010 Q1 | 50.06 Million CNY | -34.45% |
| 2010 Q2 | 102.07 Million CNY | 103.87% |
| 2009 Q4 | 76.38 Million CNY | 7.65% |
| 2009 Q3 | 70.95 Million CNY | -43.98% |
| 2009 Q2 | 126.65 Million CNY | 279.98% |
| 2009 FY | 307.31 Million CNY | 12.27% |
| 2009 Q1 | 33.33 Million CNY | -58.38% |
| 2008 Q3 | 53.22 Million CNY | 0.0% |
| 2008 Q4 | 80.07 Million CNY | 50.46% |
| 2008 FY | 273.72 Million CNY | 9.85% |
| 2007 FY | 249.17 Million CNY | 27.91% |
| 2006 FY | 194.8 Million CNY | 0.0% |